Fall Line Capital | Activity | F4

Team Portfolio Raise Champions Essays

F4/Fall Line Capital/Activity

Fall Line Capital Activity

Every public signal F4 has attached to this firm, with sources and cross-entity links.

Types

Time range

3 investments· OCT 2025 – JAN 2026Show all

Investment

Participated in Ethernovia's $90M+ Series B to scale autonomy and physical-AI networking chips, led by Maverick Silicon.

Ethernovia

Ethernovia Fall Line Capital

techcrunch.comJAN 20, 2026

JAN 20, 2026

Investment

Participated in Ukko's $45M Series C for food-allergy immunotherapy, led by Israel Biotech Fund.

Ukko

Ukko Fall Line Capital

biospace.comJAN 8, 2026

JAN 8, 2026

Investment

Joined Ansa Biotechnologies' board and cap table via its $54.4M Series B for enzymatic DNA synthesis.

Ansa Bio

Ansa Bio Fall Line Capital

fiercepharma.comOCT 1, 2025

OCT 1, 2025

Exit

Portfolio company Trace Genomics was acquired by Miraterra.

Trace Genomics

Trace Genomics Fall Line Capital

prnewswire.comJUL 7, 2025

JUL 7, 2025

Investment

Fall Line Endurance Fund was lead investor in the agreement to acquire and take GreenLight Biosciences private.

Greenlight Biosciences

Greenlight Biosciences Fall Line Capital

omm.comMAY 30, 2023

MAY 30, 2023